Your browser doesn't support javascript.
loading
Blockade of CTLA-4 and PD-1 Enhances Adoptive T-cell Therapy Efficacy in an ICOS-Mediated Manner.
Shi, Lewis Zhichang; Goswami, Sangeeta; Fu, Tihui; Guan, Baoxiang; Chen, Jianfeng; Xiong, Liangwen; Zhang, Jan; Ng Tang, Derek; Zhang, Xuejun; Vence, Luis; Blando, Jorge; Allison, James P; Collazo, Renata; Gao, Jianjun; Sharma, Padmanee.
Afiliación
  • Shi LZ; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Goswami S; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Fu T; Immunotherapy Platform, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Guan B; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Chen J; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Xiong L; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Zhang J; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Ng Tang D; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Zhang X; Immunotherapy Platform, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Vence L; Immunotherapy Platform, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Blando J; Immunotherapy Platform, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Allison JP; Immunotherapy Platform, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Collazo R; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Gao J; Immunotherapy Platform, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Sharma P; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Cancer Immunol Res ; 7(11): 1803-1812, 2019 Nov.
Article en En | MEDLINE | ID: mdl-31466995
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Inmunoterapia Adoptiva / Linfocitos T CD8-positivos / Antígeno CTLA-4 / Proteína Coestimuladora de Linfocitos T Inducibles / Receptor de Muerte Celular Programada 1 Límite: Animals / Humans Idioma: En Revista: Cancer Immunol Res Año: 2019 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Inmunoterapia Adoptiva / Linfocitos T CD8-positivos / Antígeno CTLA-4 / Proteína Coestimuladora de Linfocitos T Inducibles / Receptor de Muerte Celular Programada 1 Límite: Animals / Humans Idioma: En Revista: Cancer Immunol Res Año: 2019 Tipo del documento: Article